Neurology® Podcast Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Dec 8, 2022
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Myosenia Gravis and the Rhinomax Trial
01:48 • 4min
Multiple Sclerosis Trials - Hit Hard Early?
06:08 • 4min
What Is the Difference Between a QMG Score of Four and a Minimal Decision Manifestation?
09:42 • 2min
Retaximab for Multiple Sclerosis - What Do You Think?
11:45 • 2min
Is There a Role for Retreating Patients With Late Onset Myosynia?
13:49 • 3min
Multiple Sclerosis - Hit Hard Early?
16:33 • 5min